GLOBAL BLOOD THERAPE

GBT

Delayed - 02/26 04:00:00 pm
42.6USD	-2.07%

02/26/21 \| 02:20pm	SVB Leerink Global Healthcare Conference
03/01/21 \| 11:40am	Cowen Health Care Conference
03/01/21 \| 02:40pm	Non-Malignant Hematology Conference - Panel
05/12/21	Q1 2021 Earnings Release (Projected)

02/24/21 \| 04:30pm	FY 2020 Earnings Call
02/24/21	FY 2020 Earnings Release
01/12/21 \| 11:40am	JP Morgan Healthcare Conference
12/07/20	Analyst & Investor Day

02/26/21 \| 04:35pm	REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 010
02/26/21	REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 290
02/26/21	REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 447
02/26/21	REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 425

02/25/21 \| 01:40pm	GILEAD SCIENCES, INC. : SVB Leerink Global Healthcare Conference
02/25/21 \| 01:40pm	EXACT SCIENCES CORPORATION : SVB Leerink Global Healthcare Conference
02/25/21	IOVANCE BIOTHERAPEUTICS, INC. : FY 2020 Earnings Release
02/25/21	VIR BIOTECHNOLOGY, INC. : FY 2020 Earnings Release

Previous year

Next Year

Annual results		2016	2017	2018	2019	2020	2021 (e)
Sales M $	Released Forecast Spread				2,11 0,52 303%	124 121 1,9%	211
Operating income (EBITDA) M $	Released Forecast Spread	-81,9 -76,7 -6,8%	-118 -111 -5,8%	-178 -174 -2,2%	-281 -250 -12%	-236 -233 -1,1%	-235
Operating profit (EBIT) M $	Released Forecast Spread	-83,1 -78,0 -6,6%	-119 -111 -7,8%	-183 -179 -2,0%	-290 -260 -11%	-244 -245 0,27%	-241
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-82,5 -78,0 -5,7%	-117 -108 -8,7%	-174 -172 -1,2%	-267 -246 -8,4%	-248 -245 -0,95%	-242
Net income M $	Released Forecast Spread	-82,5 -78,1 -5,5%	-117 -108 -8,8%	-174 -172 -1,2%	-267 -246 -8,4%	-248 -245 -0,91%	-244
EPS $	Released Forecast Spread	-2,48 -2,33 -6,2%	-2,76 -2,53 -9,0%	-3,41 -3,35 -1,7%	-4,57 -4,22 -8,3%	-4,04 -3,99 -1,3%	-3,74
Announcement Date		03/13/2017	02/27/2018	02/27/2019	02/26/2020	02/24/2021

Previous period

Next period

Quarterly results		2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1 (e)	2021 Q2 (e)	2021 Q3 (e)	2021 Q4 (e)	2022 Q1 (e)
Sales M $	Released Forecast Spread						2,11 0,56 278%	14,1 3,65 287%	31,5 19,1 65%	36,9 44,6 -17%	41,3 39,1 5,7%	43,4	47,6	55,0	64,3	59,0
Operating income (EBITDA) M $	Released Forecast Spread	-44,3 -42,8 -3,4%	-50,0 -45,8 -9,2%	-50,4 -54,8 7,9%	-58,7 -59,6 1,5%	-66,6 -62,5 -6,6%	-105 -70,6 -49%	-71,2 -96,0 26%	-48,7 -67,5 28%	-57,0 -41,4 -38%	-59,0 -57,9 -1,9%	-64,9	-66,0	-64,4	-73,4
Operating profit (EBIT) M $	Released Forecast Spread	-45,5 -45,1 -0,80%	-52,1 -48,1 -8,2%	-52,5 -52,3 -0,52%	-60,8 -55,9 -8,7%	-68,7 -66,5 -3,4%	-108 -78,5 -37%	-73,5 -93,3 21%	-52,0 -71,1 27%	-58,3 -42,8 -36%	-60,4 -61,2 1,3%	-62,1	-63,1	-62,4	-60,4	-44,2
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-43,1 -44,2 2,5%	-49,2 -46,9 -4,9%	-48,9 -51,2 4,5%	-57,3 -54,0 -6,1%	-64,5 -64,0 -0,82%	-96,0 -75,4 -27%	-73,0 -91,5 20%	-52,8 -70,4 25%	-59,9 -42,1 -42%	-61,8 -60,3 -2,5%	-62,1	-62,9	-60,0	-55,8	-44,0
Net income M $	Released Forecast Spread	-43,1 -44,2 2,5%	-49,2 -46,9 -4,9%	-48,9 -51,2 4,5%	-57,3 -54,0 -6,1%	-64,5 -64,0 -0,82%	-96,0 -75,4 -27%	-73,0 -91,5 20%	-52,8 -70,5 25%	-59,9 -42,6 -41%	-61,8 -60,0 -3,0%	-63,6	-65,0	-61,2	-57,9	-46,6
EPS $	Released Forecast Spread	-0,83 -0,84 0,97%	-0,93 -0,87 -6,8%	-0,87 -0,93 6,2%	-1,01 -0,95 -6,3%	-1,07 -1,06 -0,75%	-1,59 -1,25 -27%	-1,20 -1,51 21%	-0,86 -1,15 25%	-0,97 -0,72 -35%	-1,00 -0,96 -4,7%	-1,00	-0,99	-0,93	-0,86	-0,79
Announcement Date		11/06/2018	02/27/2019	05/08/2019	08/07/2019	11/07/2019	02/26/2020	05/06/2020	08/05/2020	11/05/2020	02/24/2021